Analgesics - Global Strategic Business Report

Brochure More information from http://www.researchandmarkets.com/reports/338926/ Analgesics - Global Strategic Business Report Description: This rep...
Author: Gyles Dickerson
2 downloads 4 Views 71KB Size
Brochure More information from http://www.researchandmarkets.com/reports/338926/

Analgesics - Global Strategic Business Report Description:

This report analyzes the worldwide markets for Analgesics in US$ Million by the following segments: Internal Analgesics, (Aspirin, Acetaminophen, Ibuprofen, and Others (includes combination drugs)), and External Analgesics. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2007 through 2015. A six-year historic analysis is also provided for these markets. The report profiles 137 companies including many key and niche players such as Bayer Consumer Care, Johnson & Johnson, McNeil Consumer Healthcare, Novartis International AG, Pfizer, Inc., Reckitt Benckiser Group Plc, and Sanofi Aventis S.A. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying

Contents:

ANALGESICS A GLOBAL STRATEGIC BUSINESS REPORT

CONTENTS

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS Study Reliability and Reporting Limitations 1 Disclaimers 2 Data Interpretation & Reporting Level 2 Quantitative Techniques & Analytics 3 Product Definitions and Scope of Study 3 1. Internal Analgesics 3 Aspirin 3 Acetaminophen 3 Ibuprofen 4 Others 4 2. External Analgesics 4 2. GLOBAL ANALGESICS MARKET OVERVIEW 5 Pain Therapeutic Market 5 Analgesics Market - Offering Immense Potential 5 Internal Analgesics - The Largest & Fastest Growing Market 5 Liquid Analgesics Register Rapid Growth 6 Neuropathic Pain - Unexplored 6 Ibuprofen Scoring High 6 External Analgesics - Loosing Sheen 6 Topical Analgesics Market: Current Picture 7 Competitive Scenario 7 Global Analgesics Market (2007): Leading Analgesics Brands by Manufacturer 7 3. PRODUCT OVERVIEW A Brief History

8 8

1

Analgesics 8 Definition 8 Types of Pain 8 Acute Pain 8 Chronic Pain 9 Drugs Combating Pain 9 Local Anesthetics 9 Narcotic Opioids 10 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) 10 Types of NSAIDS 10 Common NSAIDs 11 Clinical Use... 12 Side Effects... 12 Aspirin 13 The Wonder Drug... 13 PolyAspirin: The Safer and More Potent Polymer Variant of Aspirin 13 Mode of Action 13 Contraindications 14 Acetaminophen 14 Acetaminophen Protects Heart Muscle 14 Acetaminophen Reduces Incidence of Ovarian Cancer 15 Ibuprofen, Ketoprofen and Naproxen 15 Combination Analgesics 15 Table 1: Opioid Analgesics Market: Percentage Share of Opioid / Acetaminophen Combination Products in the Opioid Script Volume (includes corresponding Graph/Chart) 16 OTC Analgesics: An Overview 16 4. INDUSTRY DYNAMICS 17 Escalating R&D Costs: A Boon or Bane? 17 Timeline of the Drug Approval Process 17 Cox II Crisis Tarnishes Industry Growth 17 Novel Therapies to Propel Opioid and Non-Opioid Therapies Rx-to-OTC Switch 18 Why Consumers Prefer OTC Drugs? 18 Development of Analgesic Tripeptides 18

18

5. RECENT CLINICAL TRIALS 19 PLx Initiates Clinical Trial For Aspirin-PC 19 Neurodiscovery Receives Approval for NSL-101 Phase II Clinical Trials 19 6. PRODUCT INTRODUCTIONS/INNOVATIONS 20 Victory Pharma Unveils Naprelan Dose Card 20 Nutra Pharma Commences Online Sales of Cobroxin 20 Nutra Pharma to Introduce Nyloxin Rx 20 Dr Reddy’s Rolls Out Finrid 20 MIP Technologies and Supelco Introduce Unique SPE Product 21 Novartis Introduces Voltaren AC Product Line 21 ProEthic Pharmaceuticals Releases Ibudone for Acute Pain Management 21 Dr. Reddy’s Laboratories Introduces Supanac for Acute Pain Management 21 Teva Pharmaceutical Announces the Launch of Fentanyl Transdermal System 22 Dr. Reddys Laboratories Introduces Supanac NSAID Drug 22 7. PRODUCT INNOVATIONS/LAUNCHES IN RECENT PAST - A PERSPECTIVE BUILDER 23 Mallinckrodt Introduces Magnacet™ Tablets for Pain Management 23 Wockhardt to Launch New Painkiller 23 Paladin Labs and Labopharm Introduce Tridural™ 23

Shionogi & Co Introduces OxiNorm Powder 0.5% 23 McNeil Brings Chewable TYLENOL® GoTabs Tablets 23 Barr Unveils Generic Version of ACTIQ® 24 Novartis Launches Voltarol Pain-Eze Emulgel. 24 TheraQuest Launches TQ-1017 24 Mentholatum Company Introduces WellPatch Deep Heat Patch

24

8. PRODUCT APPROVALS 25 Par Pharmaceutical Secures Approval for Marketing Tramadol ER 25 Cipher Acquires Tentative Approval for Tramadol ER Capsules 25 Lannett Receives Approval for Developing Hydromorphone Hydrochloride Tablets 25 King Pharmaceuticals Receives Approval for Embeda Pain-Relief Capsules 25 Sangart Secures EC’s Orphan Drug Designation for MP4CO 26 Biovail Secures Canadian Approval for Ralivia 26 Elite Pharmaceuticals and PharmaNetwrok Receive FDA Approval 26 9. RECENT INDUSTRY ACTIVITY 27 China Life Insurance Inks Agreement with Sino Biopharmaceutical 27 Azur Pharma Inks Agreement with Elan Pharmaceuticals 27 Pfizer Acquires Wyeth 27 Taisho Pharmaceutical Takes Over OTC Drugs Business of Bristol-Myers Squibb 27 Piramal Healthcare Acquires Minrad International 28 Biocon Acquires Bulk Pharmaceuticals Unit of Hindujas 28 Abbott Acquires PG110 from PanGenetics 28 Sanofi-aventis Mexico Takes Over Laboratorios Kendrick 28 WraSer Acquires e5 Pharma’s Trezix 28 Astellas Acquires Exclusive rights to Pain-Relief Drug from Neuroges 29 Henan Lingrui Pharma Commences Construction of New Analgesic Factory 29 Labopharm Europe Enters into Agreement with Merck Sharp & Dohme 29 Cumberland Pharmaceuticals Enters into a Commercialization Agreement with DB Pharm Korea 29 Cumberland Pharmaceuticals Inks an Exclusive Agreement with Phebra 30 Mallinckrodt Acquires Rights of Exalgo Extended-Release Tablets from Neuromed 30 Labopharm Europe and Grunenthal Sign Distribution and Supply Agreement 30 Timm Medical and Ferring Co-promote Prosed DS in the US 30 Competitive Technologies and Fintrade Medical Ink Sales and Distribution Agreement 31 Accumetrics and Endotech Ink Exclusive Distribution Agreement 31 Astellas and NeurogesX Sign Distribution and Marketing Agreement 31 Akela Pharma Inks Agreement with Teikoku Seiyaku 31 Medical Nutrition Inks Exclusive Licensing Agreement with DSE Healthcare 32 Echo Therapeutics Inks a Licensing Deal with Ferndale Pharma 32 Circ Pharma Signs a Development Agreement with Elan 33 Orexo Inks Distribution Agreement with Neopharm 33 Orexo Inks Agreement with NovaMed Pharmaceuticals 33 Pharmos and Reperio Enter into Agreement 33 Caraco Pharmaceutical Launches Oxycodone Hydrochloride Tablet 34 Purdue Pharma Provides Labopharm’s RYZOLT 34 Bayer Acquires Sagmel’s OTC Business 34 E5 Pharma Receives Approval from FDA 34 Pharmaceutical Associates Receives Approval from FDA 34 Concord Receives New Drug Approvals 35 Hisamitsu Receives Approval for SALONPAs® 35 Johnson & Johnson Submits NDA to FDA 35

Nycomed and Paladin Inks Joint-Promotion Agreement for Tridural 35 Akela Extends Agreement with Janssen 35 Daiichi and Lead Chemical Receives Approval for LoxoninÒ Tape 35 Tokio Marine Capital Acquires Showa Yakuhin Kako 36 Corgenix Collaborates with Randox Laboratories 36 Corgenix Receives EPO Approval for Aspirin Resistance Method 36 IOL to Expand Production Capacity 36 American Oriental Bioengineering Partners with China Aoxing 36 Abraxis Takes Over Shimoda and its Subsidiary Company 36 Church & Dwight Snaps Up Del Pharmaceuticals from Coty 37 Sosei Group Corp Re-Acquires Rights to Commercialize AD 923 37 ProStrakan Group Inks Agreement with Paladin Labs 37 Anika Therapeutics Inks Distribution Agreement with DePuy Mitek 38 Wyeth Acquires ThermaCare Brand from P&G 38 Albemarle Appoints Dr. Reddy’s as Distributor of Bulk Ibuprofen API 38 Competitive Technologies and ELS Join Forces to Distribute Pain Management Device 39 Altea Therapeutics Partners with Hospira 39 Paladin Inks Co-Promotion Deal with Nycomed 39 AstraZeneca to Divest OTC Portfolio 40 10. CORPORTAE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER 41 Ranbaxy Receives Approval from FDA 41 Wockhardt Receives FDA Approval for DPN + APAP 41 Alpharma to Market Flector® Patch in the US 41 Auriga and Mikart Inks Agreement to Market Codein 41 Watson Receives FDA Approval for Oxycodone Hydrochloride and Ibuprofen 41 Labopharm’s Tramadol Receives Approval in Canada 41 Lion Acquires BUFFERIN® Trademark Rights 42 Grunenthal’s Extends Licensing Agreement with Ortho-McNeil 42 China Aoxing Pockets LRT 42 Anesiva Inks Joint Venture Agreement Wanbang 42 Beijing Med-Pharm Inks Agreement with Lotus Healthcare 42 LAB International Inks Licensing Agreement with Janssen Pharmaceutica 43 Three Sixty Pockets Rockford-Montgomery Labs 43 Antares Enters into License and Development Agreement for Opioid Analgesic 43 Abraxis BioScience Acquires AstraZeneca’s Analgesic Brand Portfolio 43 IntelliPharmaCeutics Inks Agreement with Larasan 43 Ranbaxy and Ethypharm Ink In-licensing Agreement 44 Elite Collaborates with TPN to Co-develop Analgesic Drug 44 Novartis Acquires Hexal Company and Major Stake in Eon Labs . 44 NovaDel Pharma Receives Patent for Buccal Sprays Technology 44 Auxilium Pharmaceuticals Enters into a Licensing Agreement with PharmaForm 44 EC Sanctions Sale of Elan’s Prialt 45 EpiCept Corp. Merges with Maxim Pharmaceuticals, Inc 45 Reckitt Benckiser plc Acquires Boots Healthcare International 45 11. FOCUS ON SELECT KEY PLAYERS Bayer Consumer Care (US) Johnson & Johnson (US) McNeil Consumer Healthcare (Canada) Novartis International AG (Switzerland) Pfizer Inc. (US) Reckitt Benckiser Group Plc (UK) Sanofi Aventis S.A. (France) 12. GLOBAL MARKET PERSPECTIVE

46 46 46 46 46 47 47 47 48

Table 2: World Recent Past, Current & Future Analysis for Analgesics by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart) 48 Table 3: World Historic Review for Analgesics by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) 49 Table 4: World 11-Year Perspective for Analgesics by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years2005,2010 & 2015(includes corresponding Graph/Chart)

50

Table 5: World Recent Past, Current & Future Analysis for Internal Analgesics by Geographic Region/ Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) 51 Table 6: World Historic Review for Internal Analgesics by Geographic Region / Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) 52 Table 7: World 11-Year Perspective for Internal Analgesics by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 53 Table 8: World Recent Past, Current & Future Analysis for Internal Analgesics by Product Segment - Aspirin, Acetaminophen, Ibuprofen, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart)

54

Table 9: World Historic Review for Internal Analgesics by Product Segment - Aspirin, Acetaminophen, Ibuprofen, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) 55 Table 10: World 11-Year Perspective for Internal Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Aspirin, Acetaminophen, Ibuprofen, and Others Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) Table 11: World Recent Past, Current & Future Analysis for Aspirin by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart) 57

56

Table 12: World Historic Review for Aspirin by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) 58 Table 13: World 11-Year Perspective for Aspirin by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2005,2010& 2015 (includes corresponding Graph/Chart) 59 Table 14: World Recent Past, Current & Future Analysis for Acetaminophen by Geographic Region/ Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart) 60 Table 15: World Historic Review for Acetaminophen by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) 61 Table 16: World 11-Year Perspective for Acetaminophen by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia- Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2005,2010 & 2015 (includes corresponding Graph/Chart)

62

Table 17: World Recent Past, Current & Future Analysis for Ibuprofen by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart) 63 Table 18: World Historic Review for Ibuprofen by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) 64 Table 19: World 11-Year Perspective for Ibuprofen by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia- Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2005,2010 & 2015 (includes corresponding Graph/Chart) Table 20: World Recent Past, Current & Future Analysis for Other Internal Analgesics by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart) 66 Table 21: World Historic Review for Other Internal Analgesics by Geographic Region/Country - US, Canada, Japan, Europe,

65

Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) 67 Table 22: World 11-Year Perspective for Other Internal Analgesics by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years2005,2010 & 2015 (includes corresponding Graph/Chart) 68 Table 23: World Recent Past, Current & Future Analysis for External Analgesics by Geographic Region/ Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 2015 (includes corresponding Graph/Chart) 69 Table 24: World Historic Review for External Analgesics by Geographic Region / Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2007 (includes corresponding Graph/Chart) 70 Table 25: World 11-Year Perspective for External Analgesics by Geographic Region /Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years2005,2010 & 2015(includes corresponding Graph/Chart) 13. THE UNITED STATES 72 A.Market Analysis 72 Current and Future Analysis 72 Pain Statistics in the US 72 Industry Overview 72 Internal Analgesics 73 Cox-2 Drugs in for Some Trouble 73 Switch to OTC Drugs 73 Table 26: US Analgesics Market (2009): Percentage Share Breakdown of Leading Manufacturers by Sales (includes corresponding Graph/Chart) 73 Table 27: US Internal Liquid Analgesics Market (2009): Percentage Share Breakdown of Leading Brands by Sales (includes corresponding Graph/Chart) 74 Table 28: US Internal Tablet Analgesics Market (2009): Percentage Share Breakdown of Leading Brands by Sales (includes corresponding Graph/Chart) 74 Table 29: Internal Analgesics Market in the US by Retail Channel (2008): Percentage Share by Value Sales for Discount Stores, Food/Drug Combination Stores, Chain Drug Stores, Supermarkets, and Independent Drug Stores (includes corresponding Graph/Chart) 75 Promotional Strategies for the Internal Analgesics 75 Table 30: Market for Internal Liquid Analgesics in the U.S. by Retail Channel (2008): Percentage Share by Value Sales for Supermarkets, Drug Stores, and Discounters (includes corresponding Graph/Chart) 75 Pediatric Analgesics: The New Kid on the Block 75 External Analgesics 76

71

Stretching Boundaries 76 Table 31: US External Analgesics Market (2007): Percentage Share Breakdown of Leading Ten Brands by Revenues (includes corresponding Graph/Chart)

76

Table 32: External Analgesics Market in the US by Retail Channel (2008): Percentage Share by Value Sales for Chain drug stores, Discount stores, Food/drug combination stores, Independent drug stores, and Supermarkets (includes corresponding Graph/Chart) 76 Rubs, Patches: Driving the External Analgesics Market 77 Patch Relief Gaining Momentum 77 B.Market Analytics 77 Table 33: US Recent Past, Current & Future Analysis for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) 77 Table 34: US Historic Review for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) 78 Table 35: US 11-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for2005,2010 & 2015(includes corresponding Graph/Chart) 79 14. CANADA 80 Market Analysis 80 Table 36: Canadian Recent Past, Current & Future Analysis for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart) 80 Table 37: Canadian Historic Review for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) 81 Table 38: Canadian 11-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for2005,2010 & 2015(includes corresponding Graph/Chart) 82 15. JAPAN 83 A.Market Analysis 83 Current and Future Analysis 83 Competitive Scenario in the Past 83 Table 39: OTC Analgesics Market in Japan (2005): Market Share of Leading Players by Value - Lion, Arax, Taisho Pharmaceutical, SS Pharmaceutical, Shionogi, and Others (includes corresponding Graph/Chart) 83

B.Market Analytics 84 Table 40: Japanese Recent Past, Current & Future Analysis for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart) 84 Table 41: Japanese Historic Review for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) 85 Table 42: Japanese 11-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for2005,2010 & 2015 (includes corresponding Graph/Chart) 86 16. EUROPE 87 A.Market Analysis 87 Current and Future Analysis 87 By Product Group/Segment 87 European Pain Management Market 87 Generics Restrain Revenue Growth 87 Popular Brands in 2004 88 Table 43: Popular Brands of Pain & Inflammation Medication in Europe (2004): Percentage Share of Aspirin, Voltaren, Ibuprofen, Nurofen, Vioxx, Celebre, Tylenol, Aulin, Anadin, and Paracetamol (includes corresponding Graph/Chart) B.Market Analytics 89 Table 44: European Recent Past, Current & Future Analysis for Analgesics by Geographic Region/Country - France, Germany, UK, Italy, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart) 89 Table 45: European Historic Review for Analgesics by Geographic Region/Country - France, Germany, UK, Italy, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) Table 46: European 11-Year Perspective for Analgesics by Geographic Region/Country - Percentage Breakdown of Dollar Sales for France, Germany, UK, Italy, Spain, Russia and Rest of Europe Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 91 Table 47: European Recent Past, Current & Future Analysis for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) 92 Table 48: European Historic Review for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$

88

90

Million for Years 2001 through 2007 (includes corresponding Graph/Chart) 93 Table 49: European 11-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 94 16a. FRANCE 95 A.Market Analysis 95 Current and Future Analysis 95 Competitive Scenario 95 Table 50: Analgesics Market in France (2005): Market Share of Leading Players by Value - Bristol-Myers Squibb, Therapix, Roche, Bayer Group, Wyeth Consumer Healthcare, and Others) (includes corresponding Graph/Chart) 95 B.Market Analytics 96 Table 51: French Recent Past, Current & Future Analysis for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart) 96 Table 52: French Historic Review for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) 97 Table 53: French 11-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for2005,2010 & 2015(includes corresponding Graph/Chart) 98 16b. GERMANY 99 A.Market Analysis 99 Current and Future Analysis 99 Competitive Scenario 99 Table 54: Analgesics Market in Germany (2005): Market Share of Leading Players by Value - Bayer Group, Boehringer Ingelheim, Wyeth Consumer Healthcare, and Others (includes corresponding Graph/Chart) 99 B.Market Analytics 100 Table 55: German Recent Past, Current & Future Analysis for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart) 100 Table 56: German Historic Review for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) 101 Table 57: German 11-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for

Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for2005,2010 & 2015(includes corresponding Graph/Chart) 102 16c. ITALY 103 A.Market Analysis 103 Current and Future Analysis 103 Competitive Scenario 103 Table 58: Analgesics Market in Italy (2005): Market Share of Leading Players by Value - Bayer Group, Angelini, Novartis, Bristol-Myers Squibb, and Others (includes corresponding Graph/Chart) 103 B.Market Analytics 104 Table 59: Italian Recent Past, Current & Future Analysis for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart) 104 Table 60: Italian Historic Review for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) 105 Table 61: Italian 11-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for2005,2010 & 2015 (includes corresponding Graph/Chart) 106 16d. THE UNITED KINGDOM 107 A.Market Analysis 107 Current and Future Analysis 107 An Overview of Analgesics Market in the UK 107 Distribution Scenario 107 Competitive Scenario 108 Table 62: Analgesics Market in the United Kingdom (2005E): Market Shares of Leading Players by Value - Boots Healthcare, GlaxoSmithKline, and Others (includes corresponding Graph/Chart) 108 B.Market Analytics 108 Table 63: UK Recent Past, Current & Future Analysis for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) 108 Table 64: UK Historic Review for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) 109 Table 65: UK 11-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for 2005,2010 & 2015(includes corresponding Graph/Chart) 110

16e. SPAIN 111 A.Market Analysis 111 Current and Future Analysis 111 Competitive Scenario 111 Table 66: Analgesics Market in Spain (2005): Market Share of Leading Players by Value - Bayer Group, Boehringer Ingelheim, Bristol-Myers Squibb, Novartis, Boots Healthcare, and Others (includes corresponding Graph/Chart) B.Market Analytics 112 Table 67: Spanish Recent Past, Current & Future Analysis for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) 112 Table 68: Spanish Historic Review for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006(includes corresponding Graph/Chart) 113 Table 69: Spanish 11-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for2005,2010 & 2015 (includes corresponding Graph/Chart) 114 16f. REST OF EUROPE 115 Market Analysis 115 Table 70: Rest of Europe Recent Past, Current & Future Analysis for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart) 115 Table 71: Rest of Europe Historic Review for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) 116 Table 72: Rest of Europe 11-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart) 117 17. ASIA-PACIFIC 118 A.Market Analysis 118 Current and Future Analysis 118 The OTC Analgesic Market 118 OTC Analgesics Market in Asia-Pacific (2004): A Comparative Analysis of the Major Regions - Australia, China and South Korea 118 B.Market Analytics 119 Table 73: Asia-Pacific Recent Past, Current & Future Analysis for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others)

111

and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart) 119 Table 74: Asia-Pacific Historic Review for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) 120 Table 75: Asia-Pacific 11-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for 2005,2010 & 2015(includes corresponding Graph/Chart) 121 18. LATIN AMERICA 122 Market Analysis 122 Table 76: Latin American Recent Past, Current & Future Analysis for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) 122 Table 77: Latin American Historic Review for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) 123 Table 78: Latin American 11-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for 2005, 2010 & 2015(includes corresponding Graph/Chart) 124 19. REST OF WORLD 125 Market Analysis 125 Table 79: Rest of World Recent Past, Current & Future Analysis for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) 125 Table 80: Rest of World Historic Review for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart) 126 Table 81: Rest of World 11-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart) 127 20. APPENDIX - POPULAR ANALGESIC BRANDS BY REGION Canada 128

128

France 128 Germany 129 United Kingdom 130 Leading Analgesics Brands for Children Italy 131 Spain 131 Rest of Europe 132 Asia-Pacific 139 Latin America 143

131

COMPETITION Total Companies Profiled: 137 (including Divisions/Subsidiaries - 179) --------Region/Country Players --------The United States 47 Canada 5 Japan 8 Europe 62 France 4 Germany 9 The United Kingdom 13 Italy 8 Spain 2 Rest of Europe 26 Asia-Pacific (Excluding Japan) 49 Middle East 6 Africa 2 ---------

Ordering:

Order Online - http://www.researchandmarkets.com/reports/338926/ Order by Fax - using the form below Order by Post - print the order form below and send to Research and Markets, Guinness Centre, Taylors Lane, Dublin 8, Ireland.

Page 1 of 2 Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607-1907 (from USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit http://www.researchandmarkets.com/contact/

Order Information Please verify that the product information is correct and select the format(s) you require. Product Name:

Analgesics - Global Strategic Business Report

Web Address:

http://www.researchandmarkets.com/reports/338926/

Office Code:

SC

Product Formats Please select the product formats and quantity you require: Quantity Electronic (PDF) Single User:

USD 4500

Hard Copy:

USD 4500 + USD 55 Shipping/Handling

Electronic (PDF) 1 - 5 Users:

USD 6300

Electronic (PDF) 1 - 10 Users:

USD 8550

Electronic (PDF) 1 - 15 Users:

USD 10800

* Shipping/Handling is only charged once per order. * The price quoted above is only valid for 30 days. Please submit your order within that time frame to avail of this price as all prices are subject to change.

Contact Information Please enter all the information below in BLOCK CAPITALS Title: First Name:

Mr

Mrs

Dr

Miss Last Name:

Email Address: * Job Title: Organisation: Address: City: Postal / Zip Code: Country: Phone Number: Fax Number: * Please refrain from using free email accounts when ordering (e.g. Yahoo, Hotmail, AOL)

Ms

Prof

Page 1 of 2

Page 2 of 2 Payment Information Please indicate the payment method you would like to use by selecting the appropriate box. Pay by credit card:

You will receive an email with a link to a secure webpage to enter your credit card details.

Pay by check:

Please post the check, accompanied by this form, to: Research and Markets, Guinness Center, Taylors Lane, Dublin 8, Ireland.

Pay by wire transfer:

Please transfer funds to: Account number

833 130 83

Sort code

98-53-30

Swift code

ULSBIE2D

IBAN number

IE78ULSB98533083313083

Bank Address

Ulster Bank, 27-35 Main Street, Blackrock, Co. Dublin, Ireland.

If you have a Marketing Code please enter it below: Marketing Code: Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to: (646) 607-1907 or (646) 964-6609 - From USA +353-1-481-1716 or +353-1-653-1571 - From Rest of World

Suggest Documents